Humana and Evolent Expand Partnership to Enhance Oncology Care
07 Novembre 2024 - 10:15PM
Business Wire
Partnership Focuses on Improving Prior
Authorization Process, Helping Drive Better Patient Outcomes
Humana Inc. (NYSE: HUM) and Evolent Health, Inc. (NYSE: EVH)
announced they have expanded their strategic medical oncology
partnership to modernize and streamline prior authorization
processes to include radiation and surgical oncology services. By
connecting all primary approaches to treating cancer, this
collaboration will help expedite approval of prior authorization
requests, improve patient access to care, and ensure timely access
to critical treatments.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20241107578119/en/
“This partnership underscores our commitment to delivering a
better healthcare experience and, most importantly, better health
outcomes for our members,” said Paul Davis, Vice President of
National Provider Network Management at Humana. “Our members
who need radiation and oncology care deserve access to
high-quality, timely care, and this collaboration will help give
them the support and care they need.”
Humana is working to simplify the prior authorization process by
leveraging Evolent's advanced technology platform and expertise
across the patient’s cancer journey. Through the Evolent platform,
providers can access the most up-to-date, clinically appropriate
therapy choices for specific clinical scenarios. Prior
authorization requests are submitted in minutes and approvals are
delivered in seconds. This connected experience, which is well
organized, simple to navigate and CMS compliant, will reduce
administrative burdens for both providers and patients and ensure
that Humana members receive timely access to high-quality care.
“We are thrilled to continue partnering with Humana to drive
meaningful change across the continuum of oncology care,” said
Dan McCarthy, President at Evolent, a health care company that
delivers proven value-based specialty care solutions to payers and
providers. “Building upon our longstanding work with Humana in
medical oncology, this national expansion into radiation therapies
and surgical procedures will help enable a more coordinated,
high-quality, and efficient experience for both members and
providers throughout the cancer journey.”
Under the expanded partnership, Evolent will serve as Humana's
designated utilization management and pathway vendor for radiation
and surgical oncology services. The partnership represents a
significant milestone in modernizing authorization processes and
underscores both companies' dedication to improving healthcare
outcomes.
About Humana
Humana Inc. is committed to putting health first – for our
teammates, customers, and company. Through our Humana insurance
services and our CenterWell health care services, we make it easier
for the millions of people we serve to achieve their best health –
delivering the care and service they need when they need it. These
efforts are leading to a better quality of life for people with
Medicare, Medicaid, families, individuals, military service
personnel, and communities at large. Learn more about what we offer
at Humana.com and at CenterWell.com.
About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for
people with complex conditions through proven solutions that make
health care simpler and more affordable. Evolent serves a national
base of leading payers and providers and is consistently recognized
as a top place to work in health care nationally. Learn more about
how Evolent is changing the way health care is delivered by
visiting evolent.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241107578119/en/
Evolent: Jamie Manfuso jmanfuso@evolent.com Humana: Kevin Smith
Ksmith305@humana.com
Grafico Azioni Evolent Health (NYSE:EVH)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Evolent Health (NYSE:EVH)
Storico
Da Dic 2023 a Dic 2024